IP38-12: Uptake of doublet and triplet therapy for men with de novo metastatic castration sensitive prostate cancer. Population-based study

Saturday, May 16, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!